California Public Employees Retirement System’s Aprea Therapeutics APRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-745
Closed -$76K 1631
2021
Q1
$76K Sell
745
-68
-8% -$7.93K ﹤0.01% 3490
2020
Q4
$80K Sell
813
-15
-2% -$7.13K ﹤0.01% 3502
2020
Q3
$398K Buy
828
+30
+4% +$16.8K ﹤0.01% 2906
2020
Q2
$619K Buy
+798
New +$524K ﹤0.01% 2553

Other funds holding APRE

California Public Employees Retirement System's APRE Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Aprea Therapeutics (APRE) in Q2 2021, closing a stake of 745 shares — an estimated $76K sold.

California Public Employees Retirement System first reported a position in APRE in Q2 2020 and held it in 4 quarters. The position peaked at $619K in Q2 2020. 50 funds tracked by Wall St. Rank hold APRE as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Aprea Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 745 Aprea Therapeutics shares in Q2 2021, an estimated $76K.
  • California Public Employees Retirement System first reported a position in Aprea Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Aprea Therapeutics position peaked at $619K in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.